Growth, Innovation, and Leadership Index for Healthcare Attractiveness (GIL-H Index), 2019

Growth, Innovation, and Leadership Index for Healthcare Attractiveness (GIL-H Index), 2019

A Data-driven Research-based Country Pipeline System to Gauge Country Competitiveness in Healthcare

RELEASE DATE
26-Jul-2019
REGION
Global
Research Code: 9AE5-00-13-00-00
SKU: CI00631-GL-DE_23360

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
CI00631-GL-DE_23360

$1,500.00

$1,125.00 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Despite global political uncertainties and a subdued economic outlook, 2019 proves to be promising for the global healthcare industry, supported by growing and more aware middle class, accelerated aging population across the globe seeking personalized medical insurance, and higher R&D budgets across the board. The adoption of digital technologies gives rise to new delivery models in which the treatment of patients moves from ‘cure’ to ‘early prevention’.

With slowing global demand as a result of the looming Sino–US trade war, privatization initiatives in Gulf, the elections in India and Indonesia, corporates are being increasingly challenged by the need to invest in technological advancements and the need to find a stable sociopolitical environment in countries.

Given these changing global market conditions, Frost & Sullivan leverages an indexing methodology to annually track the competitiveness of healthcare markets across the globe. The Growth, Innovation, and Leadership Index for Healthcare Attractiveness (GIL-H Index) essentially helps identify go-to-destinations for healthcare using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L), and Healthcare (H) pillars.

In effect, this data-driven tool allows healthcare market players to build their go-to country pipeline by evaluating not just size-related indicators (e.g., population and economic growth) but also by assessing the country’s innovation ecosystem through skilled labor availability, education expenditure, patent applications, and by analyzing business environment through logistics efficiency, ease of doing business, and political stability. The ranking process uses more than 50 indicators.

The 2019 GIL-H Index, the second edition, ranks 117 countries (with GDP equal to or more than $20 billion) based on their attractiveness; the first edition ranked 110 countries. The index generates country rankings, following the assignment of weights to the G, I, L, and H pillars and to the specific indicators under them. The 2019 version also includes comprehensive scenario-based analyses, namely disease burden scenario, health infrastructure scenario, and health spending scenario; the report uses various weight assignment and rankings to highlight how results evolve as per client requirements. The data model is also supplemented by select country profiles that highlight country-specific drivers and challenges.

Country Selection: 117 countries
Developed markets and emerging markets: 41 developed markets and 76 emerging markets
Regional Classification
• Africa: 19 countries
• Americas: 21 countries
• Asia-Pacific: 23 countries
• Central Asia: 5 countries
• Eastern Europe: 19 countries
• Middle East: 13 countries
• Western Europe: 17 countries

Author: Rituparna Majumder

Table of Contents

Research Overview—GIL-H Index

Research Methodology—GIL-H Index

GIL-H Results—Key Emerging Markets, 2019

Trends and Opportunities in Healthcare, 2019 and Beyond

Trends and Opportunities in Healthcare, 2019 and Beyond (continued)

Trends and Opportunities in Healthcare, 2019 and Beyond (continued)

Trends and Opportunities in Healthcare, 2019 and Beyond (continued)

The Need for a Country Ranking Framework

Frost & Sullivan’s Proprietary GIL Framework and Introduction to GIL-H Index

Country Coverage by Region & GDP Bracket

Research Methodology

Using GIL-H Index—A Simple 3-Step Process

Indicators Used in the GIL-H Index 2019

Indicators Used in the GIL-H Index 2019 (continued)

Indicators Used in the GIL-H Index 2019 (continued)

GIL-H Index Base Scenario

GIL-H 2019 Results, Base Scenario

GIL-H 2019 Results Explained

The United States

China

Germany

Japan

Russia

Malaysia

GIL-H Index Scenarios

2019 GIL-H Index Top 20 Countries by Scenario

Scenario Analysis

China

China (continued)

India

India (continued)

Saudi Arabia

Saudi Arabia (continued)

Mexico

Mexico (continued)

3 Key Observations

Indicators and their Weights by Scenarios, GIL-H Index, 2019

Indicators and their Weights by Scenarios, GIL-H Index, 2019 (continued)

Indicators and their Weights by Scenarios, GIL-H Index, 2019 (continued)

Indicators and their Weights by Scenarios, GIL-H Index, 2019 (continued)

Indicators and their Weights by Scenarios, GIL-H Index, 2019 (continued)

Country List, GIL-H Index, 2019

Country List, GIL-H Index, 2019 (continued)

Top 100 Countries

Global Results by Region

Global Results by Region (continued)

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

Top 100 Countries

Global Results by Region

Global Results by Region (continued)

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

Top 100 Countries

Global Results by Region

Global Results by Region (continued)

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

Top 100 Countries

Global Results by Region

Global Results by Region (continued)

Global Results by GDP Bracket

Global Results by GDP Bracket (continued)

Legal Disclaimer

List of Exhibits

List of Exhibits (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
Despite global political uncertainties and a subdued economic outlook, 2019 proves to be promising for the global healthcare industry, supported by growing and more aware middle class, accelerated aging population across the globe seeking personalized medical insurance, and higher R&D budgets across the board. The adoption of digital technologies gives rise to new delivery models in which the treatment of patients moves from ‘cure’ to ‘early prevention’. With slowing global demand as a result of the looming Sino–US trade war, privatization initiatives in Gulf, the elections in India and Indonesia, corporates are being increasingly challenged by the need to invest in technological advancements and the need to find a stable sociopolitical environment in countries. Given these changing global market conditions, Frost & Sullivan leverages an indexing methodology to annually track the competitiveness of healthcare markets across the globe. The Growth, Innovation, and Leadership Index for Healthcare Attractiveness (GIL-H Index) essentially helps identify go-to-destinations for healthcare using a robust data-driven approach, whereby countries are evaluated across multiple indicators under the Growth (G), Innovation (I), Leadership (L), and Healthcare (H) pillars. In effect, this data-driven tool allows healthcare market players to build their go-to country pipeline by evaluating not just size-related indicators (e.g., population and economic growth) but also by assessing the country’s innovation ecosystem through skilled labor availability, education expenditure, patent applications, and by analyzing business environment through logistics efficiency, ease of doing business, and political stability. The ranking process uses more than 50 indicators. The 2019 GIL-H Index, the second edition, ranks 117 countries (with GDP equal to or more than $20 billion) based on their attractiveness; the first edition ranked 110 countries. The index generates country rankings, following the assignment of weights to the G, I, L, and H pillars and to the specific indicators under them. The 2019 version also includes comprehensive scenario-based analyses, namely disease burden scenario, health infrastructure scenario, and health spending scenario; the report uses various weight assignment and rankings to highlight how results evolve as per client requirements. The data model is also supplemented by select country profiles that highlight country-specific drivers and challenges. Country Selection: 117 countries Developed markets and emerging markets: 41 developed markets and 76 emerging markets Regional Classification • Africa: 19 countries • Americas: 21 countries • Asia-Pacific: 23 countries • Central Asia: 5 countries • Eastern Europe: 19 countries • Middle East: 13 countries • Western Europe: 17 countries Author: Rituparna Majumder
More Information
No Index No
Podcast No
Author Rituparna Majumder
Industries Cross Industries
WIP Number 9AE5-00-13-00-00
Is Prebook No
GPS Codes 9A7B-EM,9A6B